Navigation Links
Pharmacyclics Reports Second Quarter 2013 Results
Date:7/31/2013

0;Jun. 30, Jun. 30, 2013201220132012Revenue:  License and milestone revenue$ 50,000$
-$   50,000$
-  Collaboration services revenue4,6842,1237,5304,050Total revenue54,6842,12357,5304,050Operating expenses*:  Research and Development45,30015,38581,08431,213  Less: Excess amounts related to Research and Development(17,377)-(17,377)-Research and Development, net27,92315,38563,70731,213  General and Administrative17,7364,22037,7628,281  Less: Excess amounts related to General and Administrative(3,006)-(3,006)-General and Administrative, net14,7304,22034,7568,281Total operating expenses42,65319,60598,46339,494Income (loss) from operations12,031(17,482)(40,933)(35,444)Interest and other income (expense), net(23)4756103Income (loss) before income taxes12,008(17,435)(40,877)(35,341)Income tax benefit3435291,3175,612Net income (loss)$ 12,351$ (16,906)$ (39,560)$ (29,729)Net income (loss) per share:Basic$
.17$
(0.24)$
(0.55)$
(0.43)Diluted$
.16$
(0.24)$
(0.55)$
(0.43)Weighted average shares used to computenet income (loss) per share:Basic72,95369,08171,94868,965Diluted77,19469,08171,94868,965* Includes share-based compensation as follows:Research and development$
3,760$
,013$   14,940$
3,708General and administrative3,10183515,4991,625$
,861$
,848$   30,439$
5,333 

 Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1)(unaudited; in thousands, except per share data)Three Months EndedSix Months EndedJun. 30,Jun. 30,Jun. 30,Jun. 30,2013201220132012GAAP net income (loss)$ 12,351$ (16,906)$ (39,560)$ (29,729)Adjustments:Research and Development share-based compensation (2)

3,7601,01314,9403,708General and Administrative share-based compensation (2)

3,10183515,4991,6256,8611,84830,4395,333Non-GAAP net income (loss)$ 19,212$ (15,058)$   (9,121)$ (24,396)GAAP net income (loss) per share - basic$
.17$
(0.24)$
(0
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
2. Pharmacyclics Reports First Quarter 2013 Results
3. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
4. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
5. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
6. Pharmacyclics, Inc. Prices Public Offering of Common Stock
7. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
8. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
9. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
10. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014  Casen Buswell has a ... muscles to harden.  His case is one of only 14 ... world.  The only hospital in the United States ... world, offering treatment with the dual wave-length laser, is Methodist ... San Antonio . Using a laser available in ...
(Date:9/18/2014)... Sept. 18, 2014  Decision Resources Group finds ... the United States , 54 percent of ... inhibitor Tafinlar for BRAF -mutation-positive unresectable or ... prescribed GlaxoSmithKline,s MEK inhibitor Mekinist. Among current non-prescribers ... percent and 43 percent, respectively) expects to prescribe ...
(Date:9/18/2014)... PLYMOUTH MEETING, Pa. , Sept. 18, 2014 /PRNewswire/ ... of innovative approaches to diagnosing and treating Autism Spectrum ... an Exclusive License Agreement with The Research Foundation for ... this Agreement, Iliad will provide a new biomarker to ... associated with susceptibility to ASD. This biomarker is expected ...
Breaking Medicine Technology:Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3
... , COLLEGE STATION, ... , MD, FACS, of The Texas Institute for Thyroid and Parathyroid ... College Station Medical Center in College Station, Texas . ... in North America to be recognized by Intuitive Surgical ...
... , Jan. 14 In the keynote address at ... Lechleiter , Ph.D., chairman and CEO of Eli Lilly and Company, ... edge in innovation and improving our focus on medical innovation,s richest ... in the coming decade.  His speech focused on bioscience innovation, a ...
Cached Medicine Technology:Milestone Achieved in Revolutionary Robotic Thyroid Surgery 2Lilly CEO Stresses Human Element in Driving Medical Innovation 2Lilly CEO Stresses Human Element in Driving Medical Innovation 3
(Date:9/18/2014)... A unique partnership to support private efforts to provide ... provide a model for similar efforts should federal officials ... of reform of the VA health system, according to ... Veterans Initiative, a joint project of philanthropic groups and ... patient care, education and other services to veterans and ...
(Date:9/18/2014)... NY (PRWEB) September 18, 2014 ItsHot.com, ... NY, is now offering a 65-80% discount on its ... a whopping 71% off on its 14K Gold Pave ... diamond band can now be bought for just $775. ... 406147. , Talking about this diamond band, a representative ...
(Date:9/18/2014)... Pathways Home Health & Hospice has ... Medical Director. Prior to accepting the directorship, Brown ... Pathways KIDS, adult palliative care, and hospice teams that ... Counties. , In her new position, Brown is ... program. She will supervise five medical directors who are ...
(Date:9/18/2014)... HealthDay Reporter THURSDAY, Sept. ... that testosterone replacement therapy effectively treats normally sagging levels of ... Drug Administration advisory panel said Wednesday. The panel, from ... of the popular drugs and require drug makers to conduct ... according to Bloomberg News . "The whole idea ...
(Date:9/18/2014)... (Sept. 17, 2014) -- Two independent groups of ... the University of Kentucky, and Charles Lowenstein, MD, ... studies exploring the role that a gene called ... , According to Whiteheart, previous genome-wide association studies ... factor that regulates a protein called Von Willebrand ...
Breaking Medicine News(10 mins):Health News:Study provides insight about providing private mental health service to veterans 2Health News:Study provides insight about providing private mental health service to veterans 3Health News:ItsHot.com Now Offering 65-80% Discount on its Striking Collection of Diamond Wedding Bands 2Health News:Dr. Ellen Brown Promoted to Chief Medical Director at Pathways Home Health & Hospice 2Health News:FDA Panel: Limit Testosterone Drug Use 2Health News:FDA Panel: Limit Testosterone Drug Use 3Health News:FDA Panel: Limit Testosterone Drug Use 4Health News:University of Kentucky research explores STXBP5 gene and its role in blood clotting 2
... gap is alive and well in heart disease, a new international ... to treatment in both heart attack and severe chest pain. ... twice as likely as men to have normal or mild results ... blockage taking up more than 50 percent of any one blood ...
... ... Flows Increase, BIRMINGHAM, Ala., May 6 HealthSouth,Corporation (NYSE: ... first quarter ended March 31, 2008. Compared to the,first quarter of ... net income increased by $76.4 million., "The results of the ...
... and,Mississippi still working to recover from the Hurricane Katrina ... Department of,Health and Human Services (HHS)., "HHS continues ... health care,problems created by Hurricane Katrina," Secretary Mike Leavitt ... make sure the citizens of these,states have continued access ...
... Today at 5:30 p.m. EDT, FRAZER, Pa., ... that a Joint Advisory Committee to the U.S. ... approval of an expanded,label for FENTORA(R) (fentanyl buccal ... opioid-tolerant patients with chronic pain conditions.,The panel expressed ...
... have shown for the first time that thrombopoietin (TPO), ... to increase platelet count in cancer patients during chemotherapy, ... heart attack. , The study, led by ... the division of cardiothoracic surgery, was published in the ...
... now register to attend TCT2008 (Transcatheter Cardiovascular Therapeutics), ... Foundation. TCT gathers leading medical researchers and clinicians ... developments in the field of interventional cardiology and ... state-of-the-art techniques and training to interventional cardiologists around ...
Cached Medicine News:Health News:Women and heart attack: Study finds failure to recognize symptoms, failure to treat appropriately 2Health News:Women and heart attack: Study finds failure to recognize symptoms, failure to treat appropriately 3Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 2Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 3Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 4Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 5Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 6Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 7Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 8Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 9Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 10Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 11Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 12Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 13Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 14Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 15Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 16Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 17Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 18Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 19Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 20Health News:HealthSouth Reports Results for First Quarter Ended March 31, 2008 21Health News:Hospitals in Louisiana and Mississippi to Receive More Katrina Recovery Grants 2Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 2Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 3Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 4Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 5Health News:Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA 6Health News:Naturally-occuring protein may be effective in limiting heart attack injury and restoring function 2Health News:Media registration now open for TCT2008 2
Inquire...
... Novas Point-of-Care Manager is ... gas and critical care ... the industry. PDM ... workstation designed to effortlessly ...
... The ISI Micro Nest is the wall-mounted organizer ... a variety of sizes and diameters. The Micro ... the right brush for the cleaning task. These ... specifically for those hard-to-clean instruments such as cannulas. ...
... is the non-silicone lubricant designed to "spot" ... lubricates sticky pivot points, hinges, box joints ... allows you to lubricate with precision. Safe ... Ideal for carts, hinges, medical equipment, and ...
Medicine Products: